20 Healthcare Stocks Moving In Monday's Pre-Market Session

Gainers

OpGen, Inc. OPGN shares moved upwards by 79.10% to $3.60 during Monday's pre-market session.

BioNTech, Inc. BNTX shares rose 54.51% to $47.79. The most recent rating by H.C. Wainwright, on Mar 9, is at Neutral, with a price target of $30.

Beyond Air, Inc. XAIR shares increased by 32.47% to $5.63.

Neon Therapeutics, Inc. NTGN stock increased by 29.45% to $1.89. The most recent rating by Morgan Stanley, on Jan 21, is at Equal-Weight, with a price target of $2.

Correvio Pharma, Inc. CORV stock moved upwards by 23.44% to $0.39.

Heat Biologics, Inc. HTBX shares moved upwards by 20.28% to $0.57. The most recent rating by Maxim Group, on Feb 6, is at Buy, with a price target of $1.

Phio Pharmaceuticals, Inc. PHIO shares increased by 17.33% to $2.37.

Aytu BioScience, Inc. AYTU stock rose 15.65% to $1.33.

Allied Healthcare Prods, Inc. AHPI stock surged 15.27% to $13.44.

Acasti Pharma, Inc. ACST stock rose 9.71% to $0.34. The most recent rating by H.C. Wainwright, on Feb 18, is at Buy, with a price target of $3.

 

Losers

Mallinckrodt, Inc. MNK stock decreased by 33.77% to $2 during Monday's pre-market session. The most recent rating by B of A Securities, on Feb 26, is at Underperform, with a price target of $3.

Oncolytics Biotech, Inc. ONCY stock decreased by 26.62% to $1.02.

Innate Pharma, Inc. IPHA shares plummeted 22.85% to $3.68.

Avinger, Inc. AVGR shares decreased by 20.97% to $0.30. The most recent rating by Aegis Capital, on Mar 9, is at Buy, with a price target of $2.

Avita Medical, Inc. RCEL shares declined 20.88% to $4.70. The most recent rating by BTIG Research, on Mar 3, is at Buy, with a price target of $10.

Dynatronics, Inc. DYNT stock declined 18.90% to $0.90.

Clovis Oncology, Inc. CLVS shares plummeted 18.33% to $4.10. The most recent rating by B of A Securities, on Jan 23, is at Neutral, with a price target of $10.

Cocrystal Pharma, Inc. COCP shares fell 18.31% to $0.67.

Bausch Health Cos, Inc. BHC shares plummeted 17.49% to $15.50. The most recent rating by SunTrust Robinson Humphrey, on Feb 20, is at Buy, with a price target of $31.

Predictive Oncology, Inc. POAI shares decreased by 17.11% to $1.55.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!